---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-033471"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:13:09.916821+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals terminates CMO Dr. Bankole A. Johnson, effective May 17, 2024

## Summary
- Company provided notice to Dr. Johnson on April 10, 2024, terminating consulting agreement.
- Termination effective May 17, 2024; Dr. Johnson will no longer serve as Chief Medical Officer.
- No successor or replacement Chief Medical Officer announced.

## SEC filing metadata
- accession: 0001213900-24-033471
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390024033471/0001213900-24-033471-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390024033471/ea020390801-8k_adialpharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-033471
- JSON: https://secwatch.observer/filing/0001213900-24-033471.json
- Plain text: https://secwatch.observer/filing/0001213900-24-033471.txt

## Key facts
- Executive change
  Dr. Bankole A. Johnson was terminated as Chief Medical Officer at ADIAL PHARMACEUTICALS, INC..
  - Action: terminated
  - Role: Chief Medical Officer
  source text: As a result of the termination of the Consulting Agreement, effective as of May 17, 2024, Dr. Johnson will no longer serve as the Company’s Chief Medical Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1513525/000121390024033471/0001213900-24-033471-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.